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ABSTRACT
Objectives: Preclinical studies found that epidural motor cortex stimulation improved motor defi-
cits after stroke, but a phase III trial in humans did not corroborate these results. The current
retrospective analysis examined subjects randomized to stimulation in order to identify features
distinguishing responders from nonresponders.
Methods: Anatomic (MRI measures of gray matter thickness and of white matter tract injury)
and physiologic methods (motor evoked responses) were examined as predictors of treatment
response.
Results: Among 60 subjects randomized to cortical stimulation, both anatomic and physiologic
measures at baseline predicted behavioral response to therapy. Anatomically, those achieving
the primary efficacy endpoint had a smaller fraction of the corticospinal tract injured by stroke
compared to those who did not (44% vs 72%, p  0.04), and rarely had severe tract injury.
Physiologically, the primary efficacy endpoint was reached more often (67%) by those with pre-
served motor evoked responses (MER) upon cortical stimulation compared to those lacking MER
(27%, p0.05). Thosewith an elicitableMER also had a lower rate of precentral gyrus injury (0%
vs 33%, p  0.05) by stroke, as compared to those lacking MER, and had higher gray matter
volume compared to those lacking MER in regions including ipsilesional precentral gyrus.
Conclusions: In this clinical stroke trial, themore that the physiologic integrity of themotor system
was preserved, the more likely that a patient was to derive gains from subsequent therapy, con-
sistent with preclinical models. Functional and structural preservation of key brain substrates are
important to deriving gain from a restorative therapy. Neurology® 2011;77:1076–1083
GLOSSARY
IQR interquartile range; MERmotor evoked response.
Stroke remains a major source of human disability. An emerging group of therapies aims to
improve function in the chronic phase of stroke, when behavioral deficits are fixed.1 This is an
issue of considerable impact, as at least 6.4 million such persons are alive in the United States
alone.2 A major question is how to distinguish patients who are likely to respond to a restor-
ative therapy from patients who are not.
The current study considers this issue in relation to a phase III clinical trial3,4 that examined
behavioral effects of epidural cortical stimulation after stroke. Preclinical studies in rodents and
in nonhuman primates suggested that this form of brain stimulation improved behavioral
outcome.5–9 Together, these studies described a biological model whereby epidural motor cor-
tex stimulation promotes motor cortex plasticity and, as a result, improves motor behavioral
status.
In the clinical trial, patients with chronic hemiparetic stroke underwent anatomic and phys-
iologic assessment of the motor system and were then randomized to either epidural cortical
stimulation plus physiotherapy or to no stimulation plus physiotherapy. The main study results
were that the 2 treatment groups did not significantly differ in the proportion of subjects who
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reached the primary composite efficacy end-
point.4 The hypothesis of the current analysis
of these data is based on the model generated
in the animal studies: the best behavioral
gains from epidural motor cortex stimulation
are found with greater anatomic and physio-
logic preservation of motor system integrity at
baseline, i.e., prior to therapy initiation.
METHODS Overall clinical trial design. The current
study analyzed data from a randomized, single-blind, multi-
center clinical trial that compared the effect of 6 weeks of sub-
threshold epidural cortical stimulation  physiotherapy with
physiotherapy alone on arm motor function in patients with
chronic stroke,3,4 which ran at 21 US sites from 2004 to 2008.
After meetings with the Food and Drug Administration, the trial
designated a subject as having reached the primary composite
efficacy endpoint, intended to represent clinically meaningful
improvement in both impairment and function of the affected
arm/hand after therapy, if the subject had both 4.5 point im-
provement in the arm motor Fugl-Meyer score (range 0–66)
and 0.21 point improvement in the Arm Motor Ability Test
score (range 0–5) at 4 weeks following end of therapy.
Entry criteria for this trial included age 21 years; stroke that
was ischemic, supratentorial, and4 months old; moderate–severe
arm motor deficits; and either wrist extension 5° or ability to
repetitively grasp. Exclusion criteria included severe neglect,
spasticity, or sensory deficit; depression; or modified Rankin
Scale4. Eligible subjects underwent baseline behavioral assess-
ments and MRI. The MRI (1.5 or 3 Tesla) included a T1-
weighted high-resolution anatomic and a fMRI scan that
contrasted rest with any of 4 hand movements, as described
elsewhere.3 Subjects lacking activation over the perirolandic
region were excluded. Subjects remaining eligible were then
randomized to epidural cortical stimulation  physiotherapy
vs physiotherapy alone.
Those subjects randomized to epidural cortical stimulation
 physiotherapy were implanted with the epidural electrode and
pulse generator; these subjects are the focus of the current analy-
sis. Subjects received subthreshold cortical stimulation during
rehabilitation therapy sessions, which occurred 5 days/week for
weeks 1–4 and 3 days/week for weeks 5–6, and consisted of 2.5
hours of task-oriented physiotherapy.3 The stimulating electrode
was placed over the area of ipsilesional primary motor cortex
activated on the baseline fMRI. Three times during the 6-week
treatment protocol (baseline prior to therapy initiation, day 6 of
therapy, and end of therapy), the electrodes were used to assess
for presence of a motor evoked response (MER), allowing sub-
ject classification as MER present or absent. This was done by
increasing stimulation current, up to maximum device output,
to determine presence or absence of visible movement in any
affected hand muscle.
Of the 94 stroke subjects randomized to the investigational
group, 60 were used in the current study, with 34 subjects ex-
cluded because the T1-weighted MRI scan was missing, cor-
rupted, or had excessive head motion artifact. Note that baseline
deficits for these 60 subjects (Fugl-Meyer score 38.9  5.8,
mean  SD) did not significantly differ from the overall 94
subjects randomized to stimulation (37.6  6.1).
Image analysis. The baseline T1-weighted MRI were analyzed
several ways. First, they were reviewed to 1) classify stroke topog-
raphy (subcortical  cortical vs subcortical only) and 2) deter-
mine whether precentral gyrus was affected or spared by stroke.
The image was then flipped along the midline for stroke
subjects with stroke in the right hemisphere, such that all images
displayed the stroke in the left hemisphere. A stroke mask was
generated for each patient by outlining the stroke lesion using
MRICron, then binarized.
Next, the degree to which stroke injured the white matter
tract descending from primary motor cortex was determined, as
described previously10; this method for determining tract-specific
injury has been found to be a significant predictor of behavioral
gains in subjects with chronic stroke undergoing motor-based
therapy.
Images were then examined using voxel-based morphometry
(VBM5 toolbox) implemented in SPM5. VBM5 employs the
unified segmentation approach using a single generative model
integrating tissue classification, bias correction, and image regis-
tration. VBM5 toolbox was used to normalize masked images,
then segment them to produce gray matter, white matter, and
CSF masks in Montreal Neurological Institute stereotaxic space;
proper normalization and tissue classification was confirmed indi-
vidually for each subject. These final tissue maps were then modu-
lated by multiplying by the Jacobian determinants, after which
maps were smoothed at 8-mm full width at half maximum.
Statistical analysis. For each subject, SPM5 was used to ana-
lyze the smoothed modulated gray matter masks, with all analy-
ses using threshold p  0.001 without correction for multiple
comparisons. One set of analyses examined gray matter in rela-
tion to physiologic integrity: a 2-sample t test compared gray
matter volumes among the 9 investigational subjects with MER
vs the 51 without MER. A second set of analysis examined differ-
ences in gray matter in relation to meeting the primary compos-
ite efficacy endpoint or not: a 2-sample t test compared gray
matter volumes among the 20 subjects who reached this end-
point vs the 40 subjects who did not; note that because few
differences were observed at threshold p  0.001 for this com-
parison, a secondary analysis was performed using the explor-
atory threshold p 0.005. A third set of analyses examined gray
matter differences between 23 healthy controls and both MER
groups. The healthy control MRIs were acquired at University of
California Irvine according to the standard protocol.
For each analysis, age and total intracranial volume (sum of
gray and white matter volumes) were added as covariates, i.e., as
Table 1 Baseline and outcomemeasuresa
Primary behavioral
endpoint met
Primary behavioral
endpoint not met p
No. 20 40
Age, y 59.6 1.7 55.6 2.6 0.18
Female/male 5/15 20/20 0.10
Dominant hand, left/right/
ambidextrous
3/16/1 5/35/0 0.31
Affected arm, left/right 6/14 13/27 0.84
Hypertension, yes/no 16/4 24/16 0.15
Time poststroke, mo 58.6 11.7 60.4 10.4 0.91
Baseline armmotor Fugl-Meyer
score (out of 66)
39.5 1.5 38.6 0.8 0.58
Final armmotor Fugl-Meyer score
(measured 4 weeks following end of
therapy)
48.5 1.9 40.6 1.2 0.0005
a Values are mean SEM.
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nuisance variables. Note that adding field strength, enrollment
site, and gender as additional nuisance variables had no effect on
results, so these were not retained in final analyses.
Chi-square and Fisher exact test were used to analyze nominal
variables, and a t test and Wilcoxon rank-sum test were used for
continuous variables, as appropriate, in relation to behavioral out-
come and in relation to MER status. All analyses were 2-tailed.
Standard protocol approvals, registrations, and patient
consents. The trial whose data were used for the current analy-
ses was clinicaltrials.gov NCT00170716. All data were obtained
with approval from local institutional review boards.
RESULTS Subjects. Table 1 presents baseline fea-
tures for the 60 subjects randomized to epidural
motor cortex stimulation in the clinical trial. Most
(n  53) were Caucasian. Of the 60, 20 reached the
composite endpoint and 40 did not; also, 9 had a
MER while 51 had no MER at any assessment. Note
that for these 9 subjects, MER did not vary over
time, being uniformly present at all 3 (baseline and
both follow-up) assessments. Baseline features did not
vary according to MER status or behavioral outcome
(table 1). For VBM comparisons with stroke subjects,
23 age-matched (58.9  3.3 years), gender-matched
(12 female/11 male) healthy controls were also studied.
Anatomic status. Corticospinal tract injury. Extent of
injury to the corticospinal tract descending from ipsile-
sional primary motor cortex correlated with behavioral
outcome but not physiologic status. Thus, extent of
tract injury was significantly lower in those reaching the
primary composite efficacy endpoint (44% [0–80],
median [interquartile range (IQR)]) as compared to
those not reaching this endpoint (72% [33–92], p 
0.036). Though the distribution of values overlapped
across the 2 groups, severe corticospinal tract injury (top
quartile of injury values, see figure 1) was present in
only one subject reaching the composite endpoint (5%)
vs 25% of those not reaching this endpoint (p 0.08,
Figure 1 Corticospinal tract injury in relation to behavior andmotor evoked responses
(A) The relationship between behavioral response to therapy, corticospinal tract (CST) injury, and physiologic status. Mild corticospinal tract injury is
defined as the bottom quartile across the entire cohort (20% of the corticospinal tract injured by stroke); moderate tract injury, the interquartile range
(IQR) (21%–88% of the tract injured); and severe tract injury, the top quartile (89%). MER motor evoked response present; MER motor evoked
response absent. (B) Extent of CST injury is presented as a function of behavioral outcome. The dashed lines indicate the bottom quartile, IQR, and top
quartile of tract injury.
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figure 1). Physiologic status did not vary with extent of
tract injury, being 44% (22–88) for MER present vs
69% (19–88) for MER absent (p 0.5).
Infarct location. Features of infarct location did not
correlate significantly with behavioral outcome, but
they did with physiologic status. Thus, the propor-
tion of subjects reaching the primary behavioral end-
point did not vary in relation to depth of stroke (p
0.098) or precentral gyrus involvement (p 0.093).
However, for subjects with MER, 100% of had a
subcortical lesion, while for those lacking an MER,
the lesion was subcortical in 41.2% and both cortical
and subcortical in 58.8% (p  0.002). Regarding
precentral gyrus involvement, stroke involved this
gyrus in none (0%) of the subjects with MER but in
33.3% of subjects lacking MER (p  0.05).
Physiologic status. A significant difference in behav-
ioral outcome was found in relation to physiology.
Those subjects from whom an MER could be elicited
had a significantly higher rate of reaching the primary
composite efficacy endpoint (67%) as compared to sub-
jects with MER absent (27%, p  0.05). Moreover,
MER, when present, were mainly in subjects reaching
the primary composite efficacy endpoint who hadmod-
erate corticospinal tract injury (figure 1A). Overlap of
binarized stroke masks (figure 2) indicates that infarcts
in subjects with preserved MER spanned a much
smaller area of white matter, compared to infarcts in
subjects lacking MER.
Gray matter volume in stroke patients who did vs did
not have MER. The anatomic underpinnings of these
observations were examined with VBM. At baseline,
patients with MER, as compared to patients without
MER, exhibited increased gray matter volumes in
brain areas that included ipsilesional precentral/post-
central gyri, bilateral anterior cingulate cortex, and
contralesional anterior striatum (table 2 and fig-
ure 3). Conversely, patients with absent MER, as
compared to patients with MER, showed increased
gray matter volume in areas including contralesional
precentral/postcentral gyri.
In order to better understand the nature of these
observed differences in gray matter volume between
stroke patients with MER vs stroke patients without
MER, each of these 2 patient subgroups were compared
with a cohort of healthy control subjects (n 23).
In most cases, when subjects with MER had larger
gray matter volume as compared to subjects without
MER (table 2), this was due to above normal (sub-
jects with MER significantly  healthy controls)
gray matter volume in subjects with MER, a pattern
observed within bilateral anterior cingulate, contral-
esional anterior striatum, ipsilesional precentral/
postcentral gyri, and ipsilesional posterior putamen.
One exception was noted, whereby subjects with
MER had larger gray matter volume than subjects
without MER due to below normal (healthy con-
trol subjects without MER) gray matter volume in
subjects without MER, within ipsilesional anterior
putamen.
When subjects without MER had larger gray mat-
ter volume as compared to subjects with MER (ta-
ble 2), this was due to above normal (subjects with
MER absent significantly  healthy controls) gray
Figure 2 Distribution of infarct locations
Infarcts were overlapped and superimposed on a normal brain template to show the distribution of infarct sites in (A)
subjects with motor evoked response (MER) present and (B) subjects lacking MER. In both cases, infarcts in these hemipa-
retic patients were centered on the central sulcus (indicated by the arrow). This representative slice demonstrates that
infarcts in subjects with preserved MER did not involve gray matter and in general spanned a much smaller area of white
matter, as compared to infarcts in subjects lacking MER.
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matter volume in the subjects without MER, a pat-
tern observed within bilateral precuneus and ipsile-
sional occipital lobe.
Gray matter volume in stroke patients who did vs did
not reach the primary composite efficacy endpoint.
There were few differences in relation to final clinical
outcome when the data were analyzed at threshold
p  0.001. However, a secondary analysis using
threshold p  0.005 disclosed that the 20 subjects
who reached the primary composite efficacy end-
point had a significantly larger volume of gray matter
within contralesional anterior striatum, ipsilesional
medial lentiform nucleus, and ipsilesional anterior
temporal lobe. Comparison with healthy controls, as
above, disclosed that this was due to above normal
volumes in subjects who reached the composite end-
point, in the case of contralesional anterior striatum.
Conversely, the 40 subjects who did not reach the
primary composite efficacy endpoint, as compared to
the 20 who did, had a significantly larger volume of
gray matter within ipsilesional medial temporal lobe,
ipsilesional midbrain, and contralesional medial
frontal lobe. Comparison with healthy controls dis-
closed that this was due to above normal volumes in
subjects who did not reach the composite endpoint,
in all 3 regions.
DISCUSSION A series of preclinical studies in ro-
dents and primates5–8 concluded that epidural motor
cortex stimulation was associated with behavioral
gains after stroke, but a phase III trial4 found that
those randomized to stimulation  physiotherapy
did not differ significantly in the proportion of sub-
jects reaching the primary composite efficacy end-
point as compared to those randomized to
physiotherapy alone. The current report focused on
trial enrollees who were randomized to stimulation,
and results support the current hypothesis, i.e., that
both anatomic and physiologic measures at baseline
distinguished responders from nonresponders.
The differences between behavioral responders
and nonresponders provide a number of insights. Re-
sponders had significantly less injury to the cortico-
spinal tract and were significantly more likely to have
preserved motor system physiology; preserved physi-
ology itself was significantly associated with subcorti-
cal stroke and supranormal gray matter volume in
regions including primary motor and sensory cortex.
These findings echo studies of natural stroke recov-
ery, for example, where an association also exists be-
tween better outcome and less corticospinal tract
injury.11,12 Treatment-induced repair is thus affected
by many of the same constraints as spontaneous re-
covery. Stroke topography might be a particularly
important factor, as subcortical stroke differs from
cortical stroke in ways such as pattern of poststroke
plasticity13,14 and of cortical excitability.15 The cur-
rent analysis found that stroke topography might in-
fluence response to therapy, consistent with a prior
study of cortical stimulation,16 and suggests that this
might be mediated through the association between
topography and physiologic integrity. The current
results reinforce recent findings17 that the best pic-
ture of brain substrate available for a restorative ther-
apy may be provided by combining anatomic and
physiologic assessments.
Regarding anatomic assessments, the current re-
sults might have value for development of biomark-
ers for stroke recovery therapeutics.18 One set of
markers relates to regional gray matter volume. Gray
matter volume in bilateral basal ganglia was associ-
ated with better behavioral outcome; in primary mo-
tor cortex, with greater physiologic integrity. Gray
matter volume is a useful predictor in other clinical
contexts, such as in hippocampus for response to
therapy in depression,19 in anterior cingulate for re-
sponse to cognitive behavioral therapy,20 and in sev-
eral cortical zones to predict clinical course in
dementia.21 Greater primary sensory cortex thickness
Table 2 Brain regions where graymatter volume differed according to
MER statusa
Cluster volume
(mm3)
MNI coordinates
(x, y, z) Anatomic locations
MER present>
MER absent
5,860 2, 33, 14 Contralesional ipsilesional anterior cingulate
5,051 23, 16, 15 Contralesional anterior striatum
449 14,24, 74 Contralesional dorsal/medial precentral gyrus
5,557 35,22, 68 Ipsilesional precentral postcentral gyrus
2,201 27,9, 14 Ipsilesional posterior putamen
720 54, 19, 32 Ipsilesional dorsolateral prefrontal cortex
798 19, 9, 6 Ipsilesional anterior putamen
871 59,12, 47 Ipsilesional precentral and postcentral gyrus
MER absent>
MER present
1,734 27,62, 2 Contralesional occipital lobe
1,006 43, 15, 27 Contralesional inferior frontal gyrus
670 17,31, 50 Contralesional medial precentral and
postcentral gyri
528 11,45, 39 Contralesional precuneus
3,783 35,53, 3 Ipsilesional occipital
1,004 39,28,16 Ipsilesional parahippocampal gyrus
828 10,51, 38 Ipsilesional precuneus
Abbreviation: MERmotor evoked response.
a Among the 60 subjects who received investigational brain stimulation during 6 weeks of
physiotherapy, an MER could be evoked in hand muscles by brain stimulation in 9 (MER
present) but could not be evoked in the other 51 subjects (MER absent). This table shows
regions where the anatomical brain MRI, taken at baseline, prior to therapy, showed signifi-
cant differences between these 2 groups.
1080 Neurology 77 September 13, 2011
has been linked with larger extent of functional plas-
ticity,22 suggesting a functional correlate to these an-
atomic findings. A second set of potential biomarkers
relates to white matter injury. Of the 20 subjects
reaching the composite endpoint, only 1 had severe
corticospinal tract injury (figure 1). Extent of corti-
cospinal tract injury predicts response to robotic
therapy after stroke.10 Such a measure might be use-
ful as an exclusion criterion in some restorative stroke
trials, for example, excluding those with severe tract
injury. Increased technological refinements23,24 sup-
port further development of anatomic measures as
biomarkers for restorative trials after stroke.
The current report provides lessons useful for fu-
ture translation of neuroplasticity-based trials.25 En-
try criteria differed between the animal and human
studies: the rodent and primate studies required pre-
served motor evoked potentials5–8 but the human
trial did not. Human patients demonstrating an
MER were 2.5 times more likely to achieve the pri-
mary composite efficacy endpoint. This highlights
the importance of aligning patient selection with the
biological model developed in preclinical studies,26
though there were other differences between preclin-
ical and clinical studies such as time poststroke and
type of stroke injury.
The current analysis had several limitations. Ex-
tent of corticospinal tract injury, while significantly
different between responders and nonresponders,
showed substantial overlap across the 2 groups, limit-
ing broader clinical trial application of this measure
in current form, though the dichotomous measure
“severe tract injury or not” might be promising. A
slightly more liberal statistical threshold was needed
to appreciate VBM differences between responders
and nonresponders. Behavioral outcome varied with
extent of corticospinal tract injury but not with in-
farct topography, while physiologic status varied
with infarct topography but not extent of corticospi-
nal tract injury. A larger extent of agreement might
have been expected between these 2 analyses. Use of
less sensitive visual methods rather than electromyo-
graphic methods to ascertain physiologic status
might have contributed to this discrepancy, and
Figure 3 Areas where subjects with preserved physiologic integrity had increased graymatter volume
Arrows indicate brain regions where subjects with MER present had significantly increased gray matter volume, relative to
subjects with MER absent. (A) Ipsilesional precentral postcentral gyrus; (B) ipsilesional dorsolateral prefrontal cortex; (C)
bilateral striatum; and (D) bilateral anterior cingulate.
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might also explain the observation that most sub-
jects who were behavioral responders lacked MER,
though other issues such as electrode placement or
stimulus parameters might also have contributed.
Nonetheless, these results together suggest that
tract injury might have greater influence on behav-
ioral response, while injury to cortex has a greater
bearing on the likelihood of eliciting an MER with
stimulation.
Injury and behavioral deficits caused by stroke
are highly variable. Optimizing the efficacy of re-
storative therapies after stroke will require match-
ing treatments with patients who have sufficient
biological target. The current analysis identified
anatomic and physiologic measures predictive of a
favorable response to epidural motor cortex stimu-
lation, and found these to be concordant with pre-
clinical investigations. These findings might have
value to the study of other restorative therapies
after stroke.
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Historical Abstract: July 1, 1985
ALZHEIMER’S DISEASE IN DOWN’S SYNDROME: CLINICOPATHOLOGIC STUDIES
KE Wisniewski, AJ Dalton, DRC McLachlan, GY Wen, HM Wisniewski
Neurology 1985;35:957-961
Clinical and neuropathologic evidence points to the development of Alzheimer’s disease (AD) in seven Down’s syndrome patients
above age 40. Dementia was observed in these patients over periods of 2.5 to 9.2 years. The first clinical sign of AD, visual memory
loss, was succeeded by impaired learning capacity and decreased occupational and social functioning, and culminated in seizures and
urinary incontinence. The morphometric observations of the brains of these seven patients with AD showed that the numbers of
plaques and tangles exceeded 20 per 1.5 X 10(6) microns2 area, in both the prefrontal and hippocampal cortices. Plaques and tangles
were also evident in the basal ganglia, thalamus, hypothalamus, and midbrain. In addition, we found that four of the seven brains
showed small strokes, and five of the seven amyloid angiopathy. This study also indicates that by longitudinal neuropsychological
evaluations and lab tests, which exclude other causes of dementia, the diagnosis of AD can be made even in severely and profoundly
retarded patients.
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Comment from Jonathan W. Mink, MD, PhD, FAAN, Associate Editor: The authors described the development of clinical
manifestations of Alzheimer disease (AD) in individuals with Down syndrome and the association of these clinical signs and
symptoms with neuropathologic changes at autopsy that are characteristic of AD. The association between Down syndrome
and AD has been substantiated in many subsequent studies.
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